Memory B cells are present in normal numbers in XBP1CD19 mice. (A, left) Representative expression of IgD and NP on [PI, CD4, CD8, F4/80, GR1]neg splenocytes of day-14 mice immunized with Ribi (adjuvant) only (left) or NP-KLH in Ribi (right). Shown are XBP1fl/fl CD19+/+ (XBP1+/+) mice (top) and XBP1fl/fl CD19cre/+ (XBP1CD19) littermates (bottom). The inset represents the percentage of cells within profile (mean ± SEM; n = 3). (A, right) Total number of IgDlo NP-specific B cells from day 0 (naive BALB/c), adjuvant only (day 14 Ribi only), day 5, and day 14 NP-KLH in Ribi immunized XBP1+/+ mice (white columns) and XBP1CD19 (black columns) mice (mean ± SEM; n = 3). (B, left) Representative expression of B220 and CD138 at the surface of IgDlo NP-specific B cells at days 5 (left) and 14 (right) from XBP1+/+ mice (top) and XBP1CD19 littermates (bottom). The inset represents the percentage of cells within profile (mean ± SEM; n = 3). (B, right) Total number of NP-specific B cells compartment B220+, CD79b+ B220lo, or CD138+ at day 5 (top) or day 14 (bottom) immunized XBP1+/+ (white columns) and XBP1CD19 (black columns) mice (mean ± SEM; n = 3; unpaired Student's t test; P > 0.05 for all data points). (C) [PI, CD4, CD8, F4/80, GR1]neg IgDlo NP+ CD138+ splenocytes of day-5 and day-14 immunized mice were sorted directly ex vivo into NP-specific Ig (IgM or IgG) revealing ELISPOT assays. Positives were scored manually under a dissection microscope. Each assay was done in triplicate from three separate animals (mean ± SEM; n = 3; unpaired Student's t test; *, P ≤ 0.05).